The benefits demonstrated at 4-months in the FACETS arm for fatigue severity and self-efficacy largely persisted , with a slight reduction in standardised effect sizes ( SES ) ( -0.29 , p = 0.06 and 0.34 , p = 0.09 , respectively ) .